Kun-yuan Y. Chiu

Nantou, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications

Temporal trends in malignancy incidence and outcomes among kidney transplantation recipients: a multi-center real-world evidence study using the TriNetX network (2000-2010 vs. 2010-2021).

Temporal trends in malignancy incidence and outcomes among kidney transplantation recipients: a multi-center real-world evidence study using the TriNetX network (2000-2010 vs. 2010-2021).

Journal: Frontiers in immunology
Published: May 10, 2025

Author Correction: Geriatric nutritional risk index as a prognostic marker for patients with upper tract urothelial carcinoma receiving radical nephroureterectomy.

Author Correction: Geriatric nutritional risk index as a prognostic marker for patients with upper tract urothelial carcinoma receiving radical nephroureterectomy.

Journal: Scientific reports
Published: December 06, 2024

Predictors of Failed Outcomes in Ureteral Reconstruction: A Real-World Retrospective Study.

Predictors of Failed Outcomes in Ureteral Reconstruction: A Real-World Retrospective Study.

Journal: Medicina (Kaunas, Lithuania)
Published: September 05, 2024

The Long-Term Functional and Oncologic Outcomes of Kidney-Sparing Surgery in Upper Tract Urothelial Carcinoma.

The Long-Term Functional and Oncologic Outcomes of Kidney-Sparing Surgery in Upper Tract Urothelial Carcinoma.

Journal: Annals of surgical oncology
Published: August 28, 2024

Enhancing screening rates for bone health management in prostate cancer patients on androgen deprivation therapy with an automated outpatient system.

Enhancing screening rates for bone health management in prostate cancer patients on androgen deprivation therapy with an automated outpatient system.

Journal: Scientific reports
Published: July 26, 2024

Impact of different visceral metastatic sites on survival in metastatic prostate cancer patients.

Impact of different visceral metastatic sites on survival in metastatic prostate cancer patients.

Journal: PloS one
Published: May 02, 2024

PI3K/Akt inhibition promotes AR activity and prostate cancer cell proliferation through p35-CDK5 modulation.

PI3K/Akt inhibition promotes AR activity and prostate cancer cell proliferation through p35-CDK5 modulation.

Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: April 01, 2024

Comparative analysis of novel hormonal agents in non-metastatic castration-resistant prostate cancer: A Taiwanese perspective.

Comparative analysis of novel hormonal agents in non-metastatic castration-resistant prostate cancer: A Taiwanese perspective.

Journal: PloS one
Published: March 01, 2024

p35/CDK5 Regulates Bladder Cancer Proliferation and Migration and Promotes Higher Tumor Grade and Poor Survival Rate in Patients With Bladder Cancer.

p35/CDK5 Regulates Bladder Cancer Proliferation and Migration and Promotes Higher Tumor Grade and Poor Survival Rate in Patients With Bladder Cancer.

Journal: Anticancer research
Published: December 19, 2023

The impact of novel hormonal agents on fracture risk in prostate cancer patients: a nationwide population-based cohort study.

The impact of novel hormonal agents on fracture risk in prostate cancer patients: a nationwide population-based cohort study.

Journal: Scientific reports
Published: November 28, 2023

Real-world study of cabozantinib treatment of advanced renal cell carcinoma in Taiwan.

Real-world study of cabozantinib treatment of advanced renal cell carcinoma in Taiwan.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: November 28, 2023

Outcome benefits of upfront cytoreductive nephrectomy for patients with metastatic renal cell carcinoma: An analysis of the TriNetX database.

Outcome benefits of upfront cytoreductive nephrectomy for patients with metastatic renal cell carcinoma: An analysis of the TriNetX database.

Journal: PloS one
Published: September 24, 2023
Showing 1-12 of 89

Last Updated: 09/26/2026